A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal product |
Forensic Toxicology |
2015-07-01 |
Vol 33 (367-373) |
Nahoko Uchiyama et al |
Consideration of the major cannabinoid agonists |
|
2009-07-00 |
|
Advisory Council on the Misuse of Drugs |
Understanding the Spice phenomenon |
|
2009-00-00 |
|
European Monitoring Centre for Drugs and Drug Addiction |
Further consideration of the synthetic cannabinoids |
|
2012-10-18 |
|
Advisory Council on the Misuse of Drugs |
GC–MS and FTIR evaluation of the six benzoyl-substituted-1-pentylindoles: Isomeric synthetic cannabinoids |
Talanta |
2014-11-01 |
Vol 129 (171-182) |
Forrest T. Smitha et al |
Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary |
Forensic Science International |
2012-01-01 |
Vol 214 (27-32) |
Péter Jankovics et al |
Synthetic cannabinoids and cathinones: prevalence and markets |
Forensic Science Review |
2013-03-01 |
Vol 25 (7-26) |
Bretteville-Jensen et al |
Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety |
Forensic Science International |
2013-03-10 |
Vol 226 (62-73) |
Vadim Shevyrin et al |
Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces. |
|
2012-09-01 |
|
Loeffler G, Hurst D, Penn A, Yung K |
Synthetic cannabinoid and marijuana exposures reported to poison centers |
Hum Exp Toxicol |
2012-10-31 |
(1006-1011) |
MB Forrester et al |
Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromato |
Forensic Science International |
2012-07-12 |
Vol 220 (e17-e22) |
Bjoern Moosmann et al |
Cannabinoid chemistry: an overview |
Cannabinoids as Therapeutics |
2005-01-01 |
(23-46) |
Lumír O. Hanuš and Raphael Mechoulam |